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Access to medication emphasizes the availability of the product at the expense of providing a service. 
The goal of this paper is to propose a theoretical model for a drug dispensing service, beginning with 
a reflection on the current realities of the Unified Health System and drug dispensation in Brazil. A 
conceptual analytical research made by a methodological course called disciplined imagination was 
mainly the approach applied to develop the model. The drug dispensing service is part of the care 
process, which considers access as an attribute; reception, connection and accountability, management, 
and clinical pharmaceutical aspects as components; and the rational use of drugs as the purpose. The 
proposed model addresses access to the dispensing service and demands a reorientation of routines, 
instruments, and practices.
Uniterms: Drugs/dispensing practice. Pharmaceutical service. Unified health system. Health services/
access.
O acesso a medicamentos enfatiza a disponibilidade do produto em detrimento da provisão de um 
serviço. O objetivo deste trabalho é propor um modelo teórico para um serviço de dispensação de 
medicamentos, iniciando com uma reflexão sobre a realidade atual do Sistema Único de Saúde e a 
dispensação de medicamentos no Brasil. Uma pesquisa analítica conceitual realizada por meio de um 
percurso metodológico chamado de imaginação disciplinada constituiu a estratégia principal para o 
desenvolvimento do modelo. O serviço de dispensação é parte do processo de cuidado, o qual considera 
o acesso como um atributo; os aspectos acolhimento, vínculo e responsabilização, gestão e clínica 
farmacêutica como componentes e o uso racional de medicamentos como o propósito. O modelo proposto 
direciona o acesso para o serviço de dispensação e demanda a reorientação de rotinas, instrumentos e 
práticas.
Unitermos: Medicamentos/prática de dispensação. Assistência farmacêutica. Sistema único de saúde. 
Serviços de saúde/acesso.
INTRODUCTION
The use of medications is steadily increasing (Lu et 
al., 2011) and is a complex socioeconomic phenomenon 
with respect to ensuring drug accessibility, rational use, 
and the ability to solve health problems (Wiedenmayer et 
al., 2006). Worldwide, drug access systems are character-
ized by excessive and careless use, the deviation of drugs 
from their intended purpose, overestimated benefits, and a 
high prevalence of drug-related problems (Wiedenmayer 
et al., 2006; Lu et al., 2011). The World Health Organiza-
tion (WHO) has examined the role of pharmaceutical ser-
vices and emphasized both their importance to health care 
and the difficulties involved in organizing such services in 
developing countries (World Health Organization, 1997; 
Wiedenmayer et al., 2006).
In terms of using the analytical categories of the 
health service utilization model developed by Andersen 
and Davidson (2007), the organization of drug dispensa-
tion can be viewed as a factor that enables the use of the 
service and influences access and health outcomes. In 
Brazil, medication costs may be covered by public health 
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services, government-subsidized copayments, or private 
payments. Legally, pharmacies are considered to be either 
commercial enterprises operating under a health license 
or part of a health care unit (Brasil, 1973).
The Brazilian Constitution of 1988 guaranteed uni-
versal and equitable access to actions and services for the 
promotion, protection, and restoration of health (Brasil, 
1988). These are the principles of the Unified Health Sys-
tem (Sistema Único de Saúde – SUS), the most significant 
social policy in Brazil, which provides pharmaceutical 
services, including drug dispensation (Brasil, 1990). 
However, during the establishment of the SUS, pharma-
cies remained isolated and disconnected from other health 
services and became anachronistic, continuing to comply 
with the regulatory framework of the 1970s, which char-
acterized pharmacy as a medication trade (Brasil, 1973). 
Despite this situation, the direct purchase of drugs by the 
Brazilian government in 2008 exceeded 1 billion U.S. 
dollars according to the exchange rate on December 30, 
2011 (Brasil, 2010). A contextual review of the Brazilian 
health system can be found in Paim et al. (2011).
Although the legal framework for drug dispensation 
has evolved, the product still affects the process, and the 
role of drugs as essential inputs for the care process has 
shifted to become the goal of the care itself. As a compo-
nent of the health system, dispensation became a purely 
administrative activity, with an emphasis on issuing pre-
scriptions and delivering drugs (Araújo, Freitas, 2006).
Brazilian studies have analyzed the inequities in 
the process of dispensation (Arrais, Barreto, Coelho, 
2007; Angonesi, 2008). Although some studies have ad-
dressed relevant issues, researchers have rarely considered 
the fundamentals of the health system’s construction, 
the health-care reform movement, and the effects of a 
market-driven economic system on dispensation (Gilbert, 
1998; Riska, 2001; Bissell, Traulsen, 2005; Waterfield, 
2010). Such studies reflect a dispensing practice that has 
developed without significant reflection on its theoretical 
framework, without evidence-based support and without 
considering the construction of pharmaceutical corporate 
knowledge. In this context, some questions remain: (1) Is 
drug dispensation designed to be a service in the health 
system? (2) How should dispensation be organized to 
incorporate the SUS principles of comprehensiveness, 
universality, and equity?
According to this context, there is a lack of theo-
retical framework throughout pharmaceutical service 
research. Therefore, there is a need to develop theoretical 
knowledge about drug dispensation to guide the develop-
ment of the care process in the pharmacy and to allow 
reflection on the pharmacist’s care practices within the 
context of public health services. The present article ad-
dresses this issue by proposing a theoretical model for a 
drug dispensing service, starting with a reflection on the 
realities of the SUS and dispensation in Brazil. The present 
work attempts to theoretically characterize drug dispensa-
tion as a service, setting out, for the first time, the access 
and the rational use of drugs connected to pharmaceutical 
service in the SUS context.
METHODOLOGY
The approach applied to develop this work was 
the conceptual analytical research as defined by Wacker 
(1998). In the theorizing and deducing process about the 
logical relations of objects, the methodological course 
called disciplined imagination comprises an evolutive 
process guided by the representation of reality. Theoreti-
cal variations of the conjectures replace the movements 
of the reality; the selection chooses theoretically the most 
adequate direction, which is selectively retained to avoid 
theoretical obstacles (Weick, 1989).
The development of the theory can be based on 
the synthesis of ideas obtained from the literature (Lee, 
Baskerville, 2003). The literature data to support the mod-
el-construction process was collected by searching Sci-
entific Electronic Library Online (SciELO), PubMed, the 
Elsevier Science Publishing House, and Google Scholar.
It involved the construction and analysis of key 
components reflecting on drug dispensation in the SUS. 
The assumptions that guided the proposition of these 
components and their relations with their environment 
and context were explained, and the conceptual clarity and 
logical consistency in arguments were sought according 
to the criteria of Fawcett (1995).
RESULTS AND DISCUSSIONS
The concept of drug dispensation in the literature
Some authors (Arrais, Barreto, Coelho, 2007; Silva 
et al., 2008; James et al., 2009; Oishi, 2009) have proposed 
technical standards and procedures for the management 
or the policy related to the dispensation and technical 
management of drug treatments. These proposals can be 
summarized as follows: (1) legal standards intended to ra-
tionalize prescriptions and control psychoactive substance 
use and costs; (2) technical and administrative procedures 
related to the organization of the unit or the health system 
bureaucracy; and (3) procedures related to professional 
standards, technical and scientific knowledge, or profes-
sional culture.
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Angonesi (2008) reviewed the scientific literature 
and the laws of Brazil and several other countries and ar-
gued that there is little theoretical reflection on the subject 
and that discussions of regulatory aspects predominate. 
The commercial interface of dispensation has contributed 
to the field’s fledgling scientific and technical-professional 
development.
Many studies do not explain their chosen concept 
or opt for a regulatory approach (Cheung, Bouvy, De 
Smet, 2009; Menolli, Ivama, Júnior, 2009; Panvelkar, 
Saini, Armour, 2009). The tacit assumptions that guide 
these studies seem to confine the dispensing activity to 
prescription checking; deliveries and instructions for the 
patient regarding drug conservation, administration, and 
precautions.
Classically, the pharmacy focuses on meeting the ex-
pectations of users and health professionals regarding drug 
availability and distribution. In the Brazilian public health 
services, pharmacies generally consist of small spaces for 
the storage and delivery of drugs, which occurs through 
a window and possibly bars. This environment reinforces 
the pharmacy’s association with the regulatory model of 
access and a curative, physician-centered approach based 
on apparent patients’ demands (Luiza, Castro, Nunes, 
1999; Araújo, Ueta, Freitas, 2005; Araújo et al., 2008). The 
presence of a pharmacist is usually linked to the dispensa-
tion of psychoactive drugs (Silva, Vieira, 2004).
The drug dispensation in Brazil is regarded as a regu-
latory activity that consists of receiving the user, checking 
the prescription, separating and distributing the drugs, and 
advising the user (Moritz, 2010). The reality is character-
ized by a large number of patients served daily, although 
only a few patients have been treated by pharmacists. Its 
organization is centered on procedures prescribed in pro-
tocols and administrative resolutions, with legal aspects 
taking precedence over clinical aspects. The concern with 
access is focused on the availability of drugs, and clinical 
aspects are limited to the safety of medication manage-
ment (Naves, Silver, 2005; Arrais, Barreto, Coelho, 2007; 
Menolli, Ivama, Júnior, 2009; Oishi, 2009).
Service is a process that applies resources and core 
professional competencies (knowledge and skills) for the 
benefit of another (Nelson, Sampat, 2001; Vargo, Lusch, 
2004). Taking that into account and considering the situ-
ation previously described, we advocate that the current 
drug dispensation does not present such characteristics, 
which are essential to classify it on service domain. For 
this purpose, the social technology (as defined later) that 
concerns a dispensing service must be established, and 
specialized professional competencies must be system-
atized. These tasks should consider the knowledge and 
skills already embodied in pharmaceutical practice in the 
health system context.
Proposed drug dispensing model for the Brazilian 
SUS
The drug dispensing service should be integrated 
into the care process in the SUS, considering access as an 
attribute; the reception, connection, and accountability, 
management, and clinical pharmaceutical as the compo-
nents; and the rational use of drugs as a purpose. Figure 1 
summarizes the proposed model.
The proposed model has been grounded on service 
system framework to set both the role to be fulfilled by 
pharmacists and the drug dispensation’s contribution in 
the health care system.
Access to health services and drugs: An attribute 
of the dispensing service
Drug dispensing services integrated into the SUS’s 
care process should be responsible not only for drug 
dispensation but also for improving user access to ser-
vices at all levels of care by identifying their needs and 
demands. The organization of public health services often 
determines the monthly dispensation of the prescription, 
whereas medical consultations occur at longer intervals 
(e.g., every three to six months).
Considering social technologies as the coordination 
of human actions that require interactions among different 
FIGURE 1 - Proposed model for drug dispensing service. 
Source: The authors
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parts through the use of routines to achieve predictable 
and specifiable results as proposed by Nelson and Sam-
pat (2001) and the characteristic autonomy of dispensary 
services, access to the dispensing service differs from 
access to drugs. Access to the dispensing service includes 
the ability to modify institutional relations (through new 
social technologies) within the service network. In this 
context, guaranteed access must consider accessibility, 
which includes such elements as the location of services, 
the conditions under which the patient may enter the 
system, and the roles of bureaucratic rules (Penchansky, 
Thomas, 1981). These aspects restrict opportunities, mod-
ulate individual and collective decisions about treatment, 
and stimulate user criticism (Trad et al., 2002; Ricketts, 
Goldsmith, 2005). Assuming that access to dispensation 
is affected by accessibility to health services, regardless of 
the legitimacy of the organizational form of these services, 
the pharmacy should help overcome prevailing inequities, 
even when this requires changing established technical 
routines and regulatory aspects.
The analysis of the relation between patients’ per-
ceived (what individual patients perceive as health needs) 
and assessed needs (professional judgments about each 
patient’s state of health) and the health care process (the 
interactions among providers’ and patients’ behaviors 
in the production of care) (Andersen, Davidson, 2007) 
allows us to infer that the supply of drugs affects health 
behavior. Drug use tends to change according to the 
available modality, namely, either a drug (i.e., a physical 
technology disconnected from the process of care) or a 
dispensing service.
In the model proposed in the present work, the orga-
nization of the dispensing service supports and qualifies 
the access attribute. Respecting the principle of the user’s 
centrality in the organization of the health system (Merhy, 
2007) accepts the premise that guaranteed access should 
be the basis of the practice model and should represent the 
starting point for the care process. Access to dispensation 
as a service with relatively predictable specific routines 
from its own technical domain would be an essential 
technological component contributing to the effective-
ness of the drugs by providing a new social technology 
and increased patient safety and reduced treatment costs.
Reception, connection, and professional 
accountability: components of dispensation
A change in dispensation involves the reorienta-
tion of the routines and social technologies. Adopting the 
premise that health care processes should be user centered, 
based on interactions among equals and relations that in-
clude listening to and being accountable for the patient’s 
needs, is to admit the need to follow the guidelines of 
reception, linking patients to their community and increas-
ing the professional accountability for this care under a 
framework of comprehensiveness (Merhy, 2007).
Reception should guide the organization and inter-
vention processes of the entire health service (Franco, 
Bueno, Merhy, 1999). Drug dispensation, in particular, 
should be integrated with the care process, helping to 
improve and consolidate previously developed practices. 
The pharmacist must “receive, listen and give a positive 
answer” (Franco, Bueno, Merhy, 1999), incorporating 
demands for drugs as part of patients’ needs and helping 
to solve health problems. To ensure comprehensiveness, 
this reception cannot be a unilateral process and should 
incorporate the community’s values to ease the tensions 
regarding the use of drugs and to define the pharmacist-
user relationship, which should be founded on ethical 
principles and citizenship. This reorientation involves 
organizing the pharmacy to listen to users and encour-
age autonomy.
The characteristics and consequences of using drugs, 
either via self-medication or a prescription, modulate 
needs, the outcomes of which surpass institutional bound-
aries. To obtain consistent results, health systems must 
articulate the responses of various institutions providing 
various levels of health care. Primary health care (PHC) 
is considered to be an essential strategy in this articulation 
(World Health Organization, 1978), and many systems 
have adopted it when organizing care processes. It is rel-
evant to the health service that drug dispensation in PHC 
accompanies and articulates a pharmacotherapeutic prac-
tice in which the patient participates, monitors emerging 
needs, and reorients relevant routines. This perspective as-
sumes that the therapeutic itinerary can respond to changes 
that were not planned for in the protocols and requires 
professional and institutional collaboration and effective 
information management (Berg, 1997; Kleinman, Eisen-
berg, Good, 2006). Thus, dispensation is not limited to the 
physical space, and the focus of the service is the user’s 
needs and the commitment to community health, reflecting 
the changes necessary to establish drug dispensation as a 
service within health systems. In this sense, incorporating 
reception as a technological component requires taking 
multidisciplinary and interdisciplinary action.
The management component of the drug 
dispensing service
Assuming that management capacity is “the capac-
ity of an organization to decide with autonomy, flexibility 
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and transparency, mobilizing resources and building the 
sustainability of management results” (Guimarães et 
al., 2004), three dimensions in the management process 
should be emphasized: organizational, operational, and 
sustainability. Barreto and Guimarães (2010) described 
characteristics, such as the understanding of the actors 
involved, decision-making autonomy, resource availabil-
ity, participation, coordination, and partnership building 
as factors affecting the management of pharmaceutical 
services (Pan American Health Organization, 2011). These 
dimensions and constraints correspond with characteris-
tics that limit the provision of a service (Meirelles, 2006; 
Maglio, Spohrer, 2008).
Management capacity, defined by the WHO as a key 
skill of the pharmacist in health care (World Health Orga-
nization, 1997), is a cardinal tool for planning and arrang-
ing the actions involved in organizing services and in the 
care process. The role of management must be recognized 
in performing the “work in act” (Merhy, 2002) of provid-
ing a drug dispensing service. The following management 
domains should be applied to the dispensing service: 
service organization and the mobilization of resources in 
the operational dimension; working conditions, person-
nel training, and coordination with the health team in the 
organizational dimension; and the workflow, the search for 
alliances, and the evaluation of results and satisfaction in 
the dimension of sustainability (Guimarães et al., 2004). 
The politicity and assessment-related aspects are linked to 
the sustainability dimension and are particularly relevant 
to the development of drug dispensation.
Regarding assessment, evidence-based manage-
ment has gained importance in decisions about how to 
organize, structure, distribute, or finance health services 
(Walshe, Rundall, 2001). In Brazil, this practice takes 
shape through the evaluations of programs and services 
that seek to increase the coherence of public health system 
management (Novaes, 2000). In this sense, the evaluation 
of dispensation must converge on a service model in which 
management activities intersect with clinical activities.
Political skill is a fundamental part of building part-
nerships in the management of dispensation. Pharmacists 
should be aware of the political influence on the health care 
model, which stems from “political action of individuals 
and groups competing for the guidance of the health sys-
tem” (Carvalho, Cunha, 2006). In this context, the goal 
is to establish a democratic health system in which the 
managements of policy and health work are a public issue 
(Merhy, 1997), and the political nature is a skill unveiled 
in the establishment of emancipatory care, which includes 
drug dispensation as a service. Management provides a 
structural axis of care in the dispensing service through 
the relations between the reception, connection and ac-
countability, and the clinical pharmaceutical components.
The clinical pharmaceutical component of the 
drug dispensing service
Studies of drug-related morbidity and mortality 
reflect increasing problems with patient safety, reduced 
drug effectiveness, and high treatment costs (Ernst, 
Grizzle, 2001; Nishtala et al., 2011; Stark, John, Leidl, 
2011). In Brazil, drugs are the leading registered cause 
of intoxication (Gandolfi, Andrade, 2006), and there is 
little consistent information about the effectiveness of 
pharmacotherapies, highlighting the urgent need for im-
provements in clinics’ social technologies. We consider 
that clinical pharmaceutical service is an essential part of 
the professional pharmacist’s work and should be devel-
oped in both theoretical dimension and pharmaceutical 
occupational culture.
The clinic can be understood as “a set of beliefs, 
positions, skills and attitudes aimed at reducing suffer-
ing, pain and disease and preventing death” (Favoreto, 
Camargo Jr, 2002). In a health system that has comprehen-
siveness as a principle, the “non-biomedical dimensions 
of diseases affect the plan of action for clinical practice” 
(Favoreto, Camargo Jr, 2002). As a component of dispen-
sation, clinical pharmaceutical involves specific routines 
to optimize the use of drugs in therapeutic projects. For 
complex clinical situations, a pharmacotherapeutic follow-
up based on a model adapted to the reality of the service 
is recommended.
Among the tools of clinical practice, protocols 
organize and standardize the therapeutic process (Ilott et 
al., 2006). However, it is necessary to reflect on the nature 
of these protocols because their rules sometimes ignore 
patient needs and can be reductionist in their dismissal of 
the complexity of health problems, limiting the availability 
of clinical options and critical professional performance 
(Berg, 1997).
The responsibility for proper outpatient care man-
agement is shared by the prescriber, the dispenser, and 
the user. The drug to be dispensed must possess all the 
characteristics that the prescription deems correct, with ap-
propriate and effective use as the proposed outcome. The 
coresponsibility of the user deserves special attention in 
treatment management. The dispensation workflow must 
consider the subject’s previous experiences, knowledge, 
beliefs, perceptions about his/her own health and his/her 
understanding of the problem; the complexity of the treat-
ment; and the type of disease. These factors are associated 
with adherence and often modulate personal decisions 
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about how to manage care (Leite, Vasconcellos, 2003; 
Gatti et al., 2009).
Supply information on the treatment and the inputs 
used to provide therapies and the corresponding attempt 
to get patient compliance are the most recognized activi-
ties of dispensation. However, the correlation between the 
provision of information and health outcomes is not clear 
(Loveman et al., 2003; Hayes et al., 2009; Brennan et al., 
2012). An innovative clinic demands the careful selection 
of information based on the patient’s cognitive abilities, 
his/her interests, needs and own sickness; promotes auton-
omy and education; and shares the power and responsibil-
ity for care. Shrank and Avorn (2007) analyzed the use of 
print media to convey information about pharmacotherapy 
and suggests a new readable and hierarchical approach to 
information presentation aimed at increasing the quality 
of communication.
A routine consisting of monitoring the patients’ 
presenting signs and establishing their correlation with 
appropriate pharmacological treatments is strategic for 
dispensation. The clinical evaluation of pharmacotherapy 
should identify vulnerable groups of users. The health unit 
staff must share these responsibilities and agree on the 
systematic recording of data by multiple professionals to 
guide drug therapy management. In this sense, the relation 
with reception, connection, and accountability structures 
an interdisciplinary approach and may contribute to im-
proved health outcomes.
Rational drug use: The purpose of the drug 
dispensing service
The promotion of rational drug use (RDU), a com-
mon pillar of drugs and pharmaceutical service policies 
in Brazil (Brasil, 1998, 2004) based on WHO guidelines, 
presents a growing challenge for equitable access. The 
WHO has defined that the rational use of drugs “demands 
that the appropriate drug be prescribed, that it be available 
at the right time at a price people can afford, that it be dis-
pensed correctly, and that it be taken in the right dose at 
the right intervals and for the right length of time” (World 
Health Organization, 1987). This rationality articulates 
the role of clinical and epidemiological knowledge in the 
semiotic interpretation of disease (Souza, 1998), which, 
by compartmentalizing subjects, socially denies them and 
distances them from their suffering (Luz, 1988).
Although the term “use” may connote a user action, 
the RDU concept expresses many actions extrinsic to 
the subject such as prescribing appropriate medication. 
Furthermore, these actions comprise social technologies 
that are related to the outcomes, such as drug effective-
ness and the curing of disease, which are multidetermined 
phenomena. These reflections reveal the epistemic gap 
at the root of the RDU concept and its implications for 
pharmaceutical practice.
The RDU concept can change according to the 
health system context in which it is applied (Almarsdót-
tir, Traulsen, 2005). To assess the rationality of use, the 
pharmacotherapeutic regimen should be considered within 
the context of the individual treatment plan, with proper 
interactions among health care levels. These observations 
indicate that rational use is a behavior of the service pro-
viders, expressed in the care process as a social phenom-
enon within the health system.
Improved drug dispensation can help establish a 
framework for rationality that is more consistent with the 
reality of health systems that follow the principles of eq-
uity and comprehensiveness, as Brazil’s health care system 
does. The RDU recommends reducing the indiscriminate 
use of drugs by patients and providers to alleviate the con-
sequences of the high prevalence of iatrogenic artifacts, in-
creasing complex drug interactions, and increasing severe 
adverse effects (Stark, John, Leidl, 2011). In this context, 
the dispensing service must promote RDU while main-
taining the patient’s autonomy as its central guideline and 
legitimizing, along with the team, the recognition that the 
patient is an active participant in the therapeutic project.
Rational use resulting from the proposed dispensing 
service does not indicate that one should be determined 
by the other. Drug treatment is recognized as a complex 
phenomenon, and its appropriateness is a challenge to the 
dispensing service. RDU is an important condition for 
achieving the desired treatment results but should not be 
regarded as the sole purpose of the care itself. Rational-
izing the use of drugs arises from organizing access to the 
dispensing service and is not solely the result of ensuring 
access to drugs.
CONCLUSION
The role of the pharmaceutical service is linked 
to pharmacists’ abilities to reflect on their professional 
practice and discover the health system’s contributions. 
The use of drugs as a health care technology should be 
studied and improved to increase the benefits to users and 
ensure their access to appropriate services. The current 
dispensing service, which includes professional efforts 
and is manifested by live labor, lacks the organization 
and theoretical support needed to contribute to the health 
system’s purpose.
The proposed theoretical model of the drug dispens-
ing service began with the assumption that, at least in part, 
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drugs are responsible for the observed treatment results 
and that their availability and distribution alone are insuf-
ficient to meet patients’ needs. The model includes access 
as an attribute and rational drug use as its purpose. In the 
model, the dispensing service is envisioned as integrating 
management, reception, connection, and accountability, 
and clinical pharmaceutical as a means of providing quali-
fied drug treatment. Proposed clinical pharmaceutical is a 
novelty because we design it as part of drug dispensation, 
and it should be provided to all patients.
As with most models, the proposed model is inten-
tionally simplistic to promote understanding. We recog-
nize the importance of work process discussions in guiding 
the drug dispensing service model. However, because of 
the complexity of the subject, such discussions were not 
used in constructing the model and are therefore not ad-
dressed in this work. Empirical studies applying the model 
could broaden its theoretical support.
The proposal of a service model for drug dispensa-
tion in the SUS opens the discussion on access to this 
service, its theoretical foundation, and the occupational 
culture. The complexity of the issue requires a broad 
debate in the pharmaceutical sciences, with the aim of 
improving the model and amplifying its perspective. Al-
though the proposed model is rooted in a Brazilian context, 
it can potentially be adapted to other countries. The context 
of the health system determines the organization of the 
services; however, some principles postulated here may 
be useful and valid in other contexts.
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